(Q34336983)

1 August 2017

0 references

Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis (English)

1 reference

1 August 2017

1 reference

diabetic macular edema

1 reference

Hui-Ping Qi

1

1 reference

1 August 2017

Sheng Bi

2

1 reference

1 August 2017

Shu-Qin Wei

3

1 reference

1 August 2017

Hao Cui

4

1 reference

1 August 2017

Jing-Bo Zhao

5

1 reference

1 August 2017

publication date

13 July 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

37

1 reference

1 August 2017

issue

12

1 reference

1 August 2017

page(s)

1136-1147

1 reference

The 14-year incidence of visual loss in a diabetic population

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Macular edema. A complication of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Diabetic macular edema. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Corticosteroids in posterior segment disease: an update on new delivery systems and new indications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intravitreal triamcinolone for refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Retinal venous pulsation and glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Posterior sub-Tenon's steroid injections for the treatment of posterior ocular inflammation: indications, efficacy and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Systemic absorption of triamcinolone acetonide after posterior sub-Tenon injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Serum levels of triamcinolone acetonide after intravitreal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Visual acuity after intravitreal triamcinolone for diabetic macular edema refractory to laser treatment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Triamcinolone-induced cataract in eyes with diabetic macular oedema: 3-year prospective data from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02713683.2012.705412

10.3109/02713683.2012.705412

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference